SUNPHARMA's weekly performance was modest, with a return of 0.87%, accompanied by moderate volatility of 15.54%. The stock's Sharpe Ratio of 0.22 indicates a relatively low risk-adjusted return. Compared to its peers, SUNPHARMA underperformed DRREDDY and HINDUNILVR, but outperformed DIVISLAB. Overall, the stock's risk profile was moderate this week.

[Volatility: 15.54%]